The global allergy immunotherapy market size was valued at USD 2.2 billion in 2022 and is poised to grow at a significant CAGR of 9.2% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future....
Market Overview:
Allergy immunotherapy, also known as desensitization or hypo-sensitization, involves administering gradually increasing doses of an allergen to a person made hypersensitive or allergic to it, with the goal of reducing the symptoms upon re-exposure. It works via subcutaneous or sublingual administration to reduce sensitivity and symptoms to otherwise harmless allergens like...
What is Allergy Immunotherapy?
Allergen immunotherapy, also known as allergy shots or desensitization, involves administering gradually increasing doses of allergens to reduce hypersensitivity and relieve allergy symptoms. It is a medical treatment for environmental allergies, including allergic rhinitis, allergic asthma, stinging insect allergy, and atopic dermatitis. The principle behind...
The Allergy Immunotherapy Market is estimated to be valued at US$ 2,116.0 million in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Allergy immunotherapy is a treatment approach that aims to decrease the sensitivity of an individual's immune system to specific allergens such...